Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcoma
Authors:
- Sophie A RichardsonSRSophie A Richardson
- Aram SafrastyanAram Safrastyan
- Mina KarimpourMina Karimpour
- Gayatri GulatiGGGayatri Gulati
- Patrick J B HarkerPHPatrick J B Harker
- Alan RedfernARAlan Redfern
- Simon P PearceSPSimon P Pearce
- Vsevolod J MakeevVMVsevolod J Makeev
- Bernadette BrennanBBBernadette Brennan
- Alexander T J LeeALAlexander T J Lee
- Alexandra ClipsonACAlexandra Clipson
- Steven M HillSHSteven M Hill
Open Access
- 6 March 2026
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (4) , 1342-1357
Abstract
Liquid biopsies and cell-free DNA (cfDNA) offer minimally invasive methods for the diagnosis and monitoring of Ewing Sarcoma (EwS). EwS have a low tumour mutational burden and their detection with plasma cfDNA is challenging. We hypothesised that analysing the cfDNA methylome and fragmentome could enhance sensitivity for detecting EwS and identifying disease recurrence. Using T7-MBD-seq, we conducted whole-genome and methylome sequencing of cfDNA from 87 serial samples of 23 patients with EwS and 3 patients with CIC-rearranged sarcoma (CIC). With EwingSign, a new machine learning model, we identified EwS or CIC in a test set for 11 out of 16 patients at diagnosis and 15 out of 18 clinically confirmed relapse events. 0 out of 24 non-cancer controls (NCC) were detected positive with EwingSign. When combined with global and regional fragmentome analysis, all 18 relapse cases were detected, with 15/18 detected by 2 or more modalities, and 1 out of 24 NCC was detected by one modality. These findings indicate that cfDNA methylome and fragmentome analysis, if validated in a larger cohort, could improve disease detection, monitoring and relapse identification in patients with EwS.Keywords
Funding Information
- Cancer Research UK (CTRNBC-2022/100001)
- Christie NHS Foundation Trust
- Children's Cancer Research Fund (DIVE/2023)
This publication has 56 references indexed in Scilit:
- Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 MutationsCancer Discovery, 2014
- The Genomic Landscape of Pediatric Ewing SarcomaCancer Discovery, 2014
- The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 MutationPLOS Genetics, 2014
- MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experimentsBioinformatics, 2013
- Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort studyThe Lancet, 2012
- Risk of recurrence and survival after relapse in patients with Ewing sarcomaPediatric Blood & Cancer, 2011
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Integrating copy number polymorphisms into array CGH analysis using a robust HMMBioinformatics, 2006
- Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumoursNature, 1992
- FREE DNA IN SERUM OF CANCER-PATIENTS AND EFFECT OF THERAPY1977